05-30-2011: Over 170 biopharma dealmakers, investors, scientists and technology transfer professionals gathered on 24 May in Munich for BioVaria 2011. Their goal was to initiate partnerships for the development of promising life-science projects originating from leading public research institutions and universities from all over Europe.
BioVaria’s Spin-off Panel was well received among business developers and venture capitalists. In a round-table setting, five selected spin-offs were briefly introduced and then challenged with exacting questions by a jury of seasoned life-science executives and investors. The most convincing candidate in terms of team, technology and business concept was selected as winner of the BioVaria Spin-off Award, worth EUR 1,000 plus professional legal consulting. This year, the award went to Dynamic Biosensors, a spin-off from the Technische Universität München (TUM) and Fujitsu Laboratories Ltd. that develops and commercializes a new technology for the real-time analysis of biomolecular interactions.
‘The Panel is a rare opportunity for spin-offs to make a pitch in a realistic situation. The tight timelines force them to nail their points exactly’, said Samuel Ogunsalu, Principal Executive, Commercial Development at Queen Mary Innovation, who moderated this year’s Spin-off Panel. ‘And for the audience, it is a great chance to learn about some really dynamic technologies and entrepreneurial teams.’
iThera Medical, a spin-off from the Helmholtz Zentrum München, has recently closed a Series A financing round with BayBG Bayerische Beteiligungsgesellschaft mbH, and Mey Capital Matrix GmbH, a Munich-based family office, as lead investor. Earlier this year, the company also secured a Phase ... more
Over 170 biopharma dealmakers, investors, scientists and technology transfer professionals gathered on 24 May in Munich for BioVaria 2011. Their goal was to initiate partnerships for the development of promising life-science projects originating from leading public research institutions and ... more
Ascenion GmbH has acquired shares in Photonion GmbH, a start-up company founded by scientists from the Helmholtz Zentrum München together with two mid-sized companies, Airsense Analytics GmbH, Schwerin, Germany, and Tofwerk AG, Thun, Switzerland. Photonion’s mission is to develop and commer ... more
Over 170 biopharma dealmakers, investors, scientists and technology transfer professionals gathered on 24 May in Munich for BioVaria 2011. Their goal was to initiate partnerships for the development of promising life-science projects originating from leading public research institutions and ... more
In the battle against cancer and other diseases, precise analysis of specific proteins can point the way toward targeted treatments. Scientists at the Technische Universitaet Muenchen (TUM), together with Fujitsu Laboratories of Japan, have developed a novel biosensor chip that not only rec ... more